Biomedical Engineering Reference
In-Depth Information
88. Yang, S.; Zhu, J.; Lu, Y.; Liang, B.; Yang, C. Body Distribution of Camptothecin Solid Lipid
Nanoparticles after Oral Administration.
Pharm. Res.
1999,
16,
751-757.
89. Morgen, M.; Lu, G. W.; Dub, D.; Stehle, R.; Lembke, F.; Cervantes, J.; Ciotti, S.; Haskell,
R.; Smithey, D.; Haley, K.; Fan, C. Targeted Delivery of a Poorly Water-Soluble Compound
to Hair Follicles using Polymeric Nanoparticle Suspensions.
Int. J. Pharm.
2011,
416
(1)
,
314-322.
90. Allen, T. M.; Mumbengegwi, D. R.; Charrois, G. J. Anti-CD19-Targeted Liposomal
Doxorubicin Improves the Therapeutic Efficacy in Murine B-Cell Lymphoma and Ameliorates
the Toxicity of Liposomes with Varying Drug Release Rates.
Clin. Cancer Res.
2005,
11,
3567-3573.
91. Chauhan, A.; Sridevi, S.; Chalasani, K.; Jain, A.; Jain, S.; Jain, N.; Diwan, P. Dendrimer-
Mediated Transdermal Delivery: Enhanced Bioavailability of Indomethacin.
J. Control
Release
2003,
90,
335.
92. Chen, X.; Schluesener, H. J. Nanosilver: A Nanoproduct in Medical Application.
Toxicol. Lett.
2008,
176,
1-12.
93. Labhasetwar, V. Nanotechnology for Drug and Gene Therapy: The Importance of Understand-
ing Molecular Mechanisms of Delivery.
Curr. Opin. Biotechnol.
2005,
16,
674-680.
94. Tiwari, S. B.; Amiji, M. M. A Review of Nanocarrier-Based CNS Delivery Systems.
Curr.
Drug. Deliv.
2006,
3,
219-232.
95. Liversidge, G. Controlled Release and Nanotechnologies: Recent Advances and Future
Opportunities.
Drug Dev. and Deliv.
2011,
11,
1.
96. Panagiotou, T.; Fisher, R. J. Enhanced Transport Capabilities via Nanotechnologies: Impact-
ing Bioefficacy, Controlled Release Strategies, and Novel Chaperones.
J. Drug. Deliv.
2011
,
1-14.
97. Singh, R.; James, W.; Lillard, J. Nanoparticle-Based Targeted Drug Delivery.
Exp. Mol. Pathol
2009,
86,
215-223.
98. Yang, L.; Cao, Z.; Sajja, H.; Mao, H.; Wang, L.; Geng, H.; Xu, H.; Jiang, T.; Wood, W.; Nie, S.;
Wang, A. Development of Receptor Targeted Iron Oxide Nanoparticles for Efficient Drug
Delivery and Tumor Imaging.
J. Biomed. Nanotech.
2008,
4,
1-11.
99. Tomalia, D.; Reyna, L.; Svenson, S. Dendrimers as Multi-Purpose Nanodevices for Oncology
Drug Delivery and Diagnostic Imaging.
Biochem. Soc. Trans.
2007,
35,
61.
100. Zhang, J. A.; Anyarambhatla, G.; Ma, L.; Ugwu, S.; Xuan, T.; Sardone, T.; Ahmad, I. Devel-
opment and Characterization of a Novel Cremophor
®
EL Free Liposome-Based Paclitaxel
(LEP-ETU) Formulation.
Eur. J. Pharm. Biopharm.
2005,
59,
177-187.
101. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in Cancer Therapy and Diagnosis.
Adv.
Drug Deliv. Rev.
2002,
54,
631-651.
102. Medina, O. P.; Pillarsettya, N.; Glekasa, A.; Punzalan, B.; Longo, V.; Gonen, M.; Zanzonico,
P.; Smith-Jones, P.; Larson, S. M. Optimizing Tumor Targeting of the Lipophilic EGFR-Bind-
ing Radiotracer SKI 243 using a Liposomal Nanoparticle Delivery System.
J. Control Release
2011,
149,
292-298.
103. Ruenraroengsak, P.; Cook, J. M.; Florence, A. T. Nanosystem Drug Targeting: Facing up to
Complex Realities.
J. Control Release
2010,
141,
265-276.
104. Kateb, B.; Chiu, K.; Black, K.; Yamamoto, V.; Khalsa, B.; Ljubimova, J.; Ding, H.; Patil, R.;
Portilla-Arias, J.; Modo, M.; Moore, D.; Farahani, K.; Okun, M.; Prakash, N.; Neman, J.;
Ahdoot, D.; Grundfest, W.; Nikzad, S.; Heiss, J. Nanoplatforms for Constructing New
Approaches to Cancer Treatment, Imaging, and Drug Delivery: What Should be the Policy?
NeuroImage
2011,
54,
S106-S124.
